<https://rdf.molmedb.upol.cz/reference/ref3871> <http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2011.07.033"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Eastwood P, González J, Gómez E, Caturla F, Balagué C, Orellana A, Domínguez M.: Indolin-2-one p38α inhibitors II: Lead optimisation. Bioorg Med Chem Lett, Volume 21 (18), 2011"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM492249>;
	<http://purl.org/ontology/bibo/pmid> "21813275"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int1027717> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3871> .
<https://rdf.molmedb.upol.cz/interaction/int1027716> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3871> .